Clinical Trials Logo
  1. Home
  2. T2DM (Type 2 Diabetes Mellitus)
  3. NCT05369078

Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects

T2DM (Type 2 Diabetes Mellitus) Clinical Trial

Official title:
Phase I Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects

Clinical Trial Summary

The purpose of this study was to investigate Safety, tolerability and pharmacokinetics in Chinese healthy subjects.

Clinical Trial Description

This was a single center, Phase 1, open-label SAD and MAD study designed to assess safety, tolerability and PK of orally administered THR-1442 tablets in Chinese healthy adults. Subjects were enrolled to receive 20mg THR-1442 tablet in Single dose group (20mg*1 day) and multiple dose group(20mg*7days). Blood samples for THR-1442 plasma concentrations were collected 0h till to 48hours. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05369078
Study type Interventional
Source Newsoara Biopharma Co., Ltd.
Contact Owen Zhang
Phone 8621-52998027
Email owen.zhang@newsoara.com
Status Recruiting
Phase Phase 1
Start date December 1, 2021
Completion date May 31, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT01373814 - Nutritional Therapy for Diabetic Cardiomyopathy
Recruiting NCT05469659 - Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Phase 2
Completed NCT05376930 - Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. Phase 3
Recruiting NCT04682795 - Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM N/A
Recruiting NCT06350890 - Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Phase 3
Completed NCT04634500 - The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. Phase 3
Recruiting NCT03789695 - RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD Phase 4
Completed NCT04632862 - The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. Phase 3
Completed NCT04688359 - Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM N/A
Completed NCT05983289 - Single Escalating Dose Study Of HSK7653 In Healthy Subjects Phase 1
Recruiting NCT04272359 - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Not yet recruiting NCT06094491 - Virtual Diabetes Group Visits Across Health Systems Phase 2
Completed NCT03467932 - A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus Phase 2
Completed NCT05376969 - Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin Phase 3
Completed NCT05279911 - Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion N/A
Active, not recruiting NCT03257449 - Effect of Viscous Soluble Fibres on Body Weight N/A
Terminated NCT04754334 - A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Phase 3
Not yet recruiting NCT06293417 - To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Not yet recruiting NCT03658031 - Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Phase 3
Terminated NCT03067480 - Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients N/A